Catalogo dei prodotti della ricerca

CIARDI, Maria Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.380
EU - Europa 2.365
AS - Asia 1.108
SA - Sud America 38
AF - Africa 31
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.310
IT - Italia 1.080
SG - Singapore 505
SE - Svezia 397
UA - Ucraina 317
IN - India 302
CN - Cina 199
FI - Finlandia 161
DE - Germania 122
IE - Irlanda 60
CA - Canada 59
GB - Regno Unito 57
ID - Indonesia 55
BG - Bulgaria 41
FR - Francia 33
AR - Argentina 32
RO - Romania 27
TG - Togo 19
MY - Malesia 17
NL - Olanda 16
BE - Belgio 11
GR - Grecia 10
RU - Federazione Russa 9
MX - Messico 8
IR - Iran 6
BR - Brasile 5
AU - Australia 4
HK - Hong Kong 4
JP - Giappone 4
MK - Macedonia 4
TR - Turchia 4
ZA - Sudafrica 4
BZ - Belize 3
CH - Svizzera 3
RS - Serbia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CZ - Repubblica Ceca 2
ES - Italia 2
HU - Ungheria 2
NG - Nigeria 2
PH - Filippine 2
PL - Polonia 2
SC - Seychelles 2
VN - Vietnam 2
AM - Armenia 1
BJ - Benin 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 7.928
Salva come PNG Salva come JPEG
Città #
Fairfield 528
Chandler 457
Rome 435
Singapore 365
Woodbridge 324
Ashburn 294
Houston 188
Wilmington 177
Ann Arbor 169
Princeton 158
Seattle 156
Cambridge 143
Plano 122
Santa Clara 122
Jacksonville 116
Dearborn 106
Boston 104
Lawrence 79
Beijing 78
Milan 73
San Paolo di Civitate 71
Dublin 55
Jakarta 54
San Diego 54
Helsinki 49
New York 45
Fremont 43
Millbury 43
Sofia 41
Andover 32
Federal 32
Toronto 28
Boardman 27
Ottawa 25
Padova 24
Norwalk 21
Lomé 19
Falls Church 18
London 17
Mannheim 17
Munich 15
Los Angeles 14
Des Moines 13
Falkenstein 13
San Mateo 13
Stockholm 13
Brussels 11
Shanghai 11
Hefei 10
Naples 9
Bühl 8
Guangzhou 8
Phoenix 8
Jinan 7
Kunming 7
Lappeenranta 7
Pune 7
Bremen 6
Buffalo 6
Mexico City 6
Paris 6
Trento 6
Verona 6
Vignola 6
Ascoli Piceno 5
Auburn Hills 5
Dallas 5
Hangzhou 5
Hyderabad 5
Latina 5
Nanchang 5
Trumbull 5
Amsterdam 4
Artena 4
Deiva Marina 4
Delhi 4
Frankfurt am Main 4
Genova 4
Hebei 4
Hong Kong 4
Induno Olona 4
Lamezia Terme 4
Leawood 4
Muizenberg 4
Perugia 4
Portland 4
Porto Recanati 4
Redmond 4
San Giovanni Rotondo 4
Wadern 4
Barrie 3
Belize City 3
Castelnuovo Rangone 3
Chapel Hill 3
Chengdu 3
Edinburgh 3
Fuzhou 3
Lidköping 3
Moscow 3
Mountain View 3
Totale 5.267
Salva come PNG Salva come JPEG
Nome #
Sepsi da Enterococcus faecium multiresistente 154
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis 119
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 105
Acute cerebellitis caused by herpes simplex virus type 1 101
Therapeutic strategy for pan-drug resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen 99
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 96
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value 94
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study. 91
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 91
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 89
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 85
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 84
HIV-2 infection in a migrant from Gambia: the history of the disease combined with phylogenetic analysis revealed the real source of infection 82
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 79
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals 79
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity 79
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. 77
Cerebrospinal fluid antiganglioside antibodies in patients with AIDS 76
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 76
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 76
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 75
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up 75
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 73
Persistent systemic microbial translocation, inflammation, and intestinal damage during Clostridioides difficile infection 72
Diagnosis of herpes simplex encephalitis with PCR 70
Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for cytomegalovirus retinitis 69
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 69
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 68
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 67
Intrathecal immune response in patients with the post-polio syndrome 66
Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy 66
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 66
Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples 66
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 65
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 65
ALCUNE CONSIDERAZIONi SULLA TERAPIA DELLA TOXOPLASMOSI CEREBRALE NEI PAZIENTI CON AIDS 64
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 64
TEST CINECA 64
The potential impact of enhanced hygienic measures during the COVID-19 outbreak on hospital-acquired infections: A pragmatic study in neurological units 64
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 64
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal 63
Quantitation of polyomavirus DNA by a competitive nested polymerase chain reaction 62
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI. 62
LA TERAPIA DEL'INFEZIONE DA PNEUMOCYSTIS CARINII IN SOGGETTI CON SINDROME DA IMMUNODEFICIENZA ACQUISITA 61
Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women: correlation with the presence of serological markers for this infection 60
In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis 60
CEREBRAL SPINAL FLUID IgG PRODUCTION IN HIV-POSITIVE PATIENTS 59
VALUTAZIONE E SIGNIFICATO DEI TESTS CUTENEI DI IPERSENSIBILITA' RITARDATA (IR) NEI PARAMETRI DI EVOLUZIONE DELL'INFEZIONE DA HIV 59
Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy. 59
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 59
Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. 59
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences 58
NMR-based metabolomics approach to study urines of chronic inflammatory rheumatic diseases patients. 57
Specific diagnostic methods for herpesvirus infections of the central nervous system: A consensus review by the European union concerted action on virus meningitis and encephalitis 57
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 57
DANNO DELLA BARRIERA EMATO-LIQUORALE IN PAZIENTI CON INFEZIONE DA HIV: CORRELAZIONE CON TNF ALFA MA NON CON IL 1B 56
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 56
A case of HIV-associated progressive multifocal leukoencephalopathy: longitudinal studyof JCV NCCR arrangement in serial CSF samples 55
HIV-associated progressive multifocal leukoencephalopathy. Current perspectives 54
Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy 54
Influence of ofloxacin on murine Peyer's patch lymphocytes 52
An unusual neurological feature of HIV-1 encephalopathy: Gerstmann's syndrome 51
Serum selenium concentration and disease progress in patients with HIV infection 51
Sarcoma di Kaposi linfonodale: iniziale manifestazione di AIDS. 51
BK virus con riarrangiamento di NCCR nel liquor cefalorachidiano di un paziente con AIDS. 51
Alterazioni neuropatologiche nell'encefalite da HIV: quadri istopatologici e clinici distinti? 51
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 51
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 50
ALTERAZIONI NEUROPATOLOGICHE NELL'ENCEFALITE DA HIV: QUADRI ISTOPATOLOGICI E CLINICI DISTINTI 50
PaO2/FiO2 ratio forecasts COVID-19 patients’ outcome regardless of age: a cross-sectional, monocentric study 49
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients 48
Considerazioni patogenetiche sulla Leucoencefalopatia Multifocale Progressiva (PML) 48
HIV-ASSOCIATED PML:AN IMMUNE-MEDIATED DEREGULATION DISEASE? 48
Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage 48
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study 48
Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19 48
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 48
Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines 48
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus 48
Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. 47
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 46
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose 45
Small fibre neuropathy frequently underlies the painful long-COVID syndrome 45
AIDS E INFEZIONI OPPORTUNISTICHE 44
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients 43
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report 43
TERAPIA CON FLUCONAZOLO NELLA INFEZIONE DA CANDIDA NEI PAZIENTI CON SINDROME DA IMMUNODEFICIENZA ACQUISITA 42
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 42
Blood biomarkers from the emergency department disclose severe omicron covid-19-associated outcomes 41
TUBERCOLOSI POLMONARE MULTIRESISTENTE (MDR-TB)COMPLICATA DA INFEZIONE NOSOCOMIALE DA P. AERUGINOSA 41
COVID-19 affects serum brain-derived neurotrophic factor and neurofilament light chain in aged men. Implications for morbidity and mortality 40
SARCOMA DI KAPOSI LINFONODALE: INIZIALE MANIFESTAZIONE DI AIDS 40
Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta 40
Bacterial infections in anti-HIV positive patients 40
Polyomaviruses NCCR sequence analysis in urothelial bladder carcinoma of immunocompetent individuals. 40
Neurofilament assessment in patients with cervical dystonia 40
Breakthrough infections after Covid-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates 39
La Real-Time PCR mediante Light Cycler nella diagnosi dell’encefalite erpetica 39
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection 39
Totale 6.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020801 0 0 0 0 0 180 155 133 96 139 63 35
2020/2021645 75 75 24 50 6 83 9 51 74 103 71 24
2021/20221.541 26 82 137 68 177 59 55 151 119 121 262 284
2022/20231.720 316 309 136 192 191 160 34 109 118 19 99 37
2023/20241.041 56 103 33 92 104 148 24 81 18 159 87 136
2024/2025966 104 142 151 211 200 158 0 0 0 0 0 0
Totale 8.286